PBPH · Portfolio Building Block World Pharma and Biotech Index ETF

The fund uses a "passive management" approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund"s net assets in component securities that make up the index. The fund is non-diversified.